These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27072691)

  • 41. Active site metal ion in UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) switches between Fe(II) and Zn(II) depending on cellular conditions.
    Gattis SG; Hernick M; Fierke CA
    J Biol Chem; 2010 Oct; 285(44):33788-96. PubMed ID: 20709752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The inhibitory and binding studies of methyl-sulfone hydroxamate based inhibitors against LpxC from drug resistant Moraxella catarrhalis using biophysical, biochemical and in silico approaches.
    Sharma A; Kumar V; Pratap S; Kumar P
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1747-1762. PubMed ID: 30017978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.
    Wang W; Maniar M; Jain R; Jacobs J; Trias J; Yuan Z
    Anal Biochem; 2001 Mar; 290(2):338-46. PubMed ID: 11237337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EXAFS studies of the zinc sites of UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC).
    McClure CP; Rusche KM; Peariso K; Jackman JE; Fierke CA; Penner-Hahn JE
    J Inorg Biochem; 2003 Feb; 94(1-2):78-85. PubMed ID: 12620676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway.
    McClerren AL; Zhou P; Guan Z; Raetz CR; Rudolph J
    Biochemistry; 2005 Feb; 44(4):1106-13. PubMed ID: 15667204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation of Pseudomonas aeruginosa LpxC Inhibitors.
    Zuo K; Liang L; Du W; Sun X; Liu W; Gou X; Wan H; Hu J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28481250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Species-specific and inhibitor-dependent conformations of LpxC: implications for antibiotic design.
    Lee CJ; Liang X; Chen X; Zeng D; Joo SH; Chung HS; Barb AW; Swanson SM; Nicholas RA; Li Y; Toone EJ; Raetz CR; Zhou P
    Chem Biol; 2011 Jan; 18(1):38-47. PubMed ID: 21167751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
    Warmus JS; Quinn CL; Taylor C; Murphy ST; Johnson TA; Limberakis C; Ortwine D; Bronstein J; Pagano P; Knafels JD; Lightle S; Mochalkin I; Brideau R; Podoll T
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2536-43. PubMed ID: 22401863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents.
    Ding S; Dai RY; Wang WK; Cao Q; Lan LF; Zhou XL; Yang YS
    Bioorg Med Chem Lett; 2018 Jan; 28(2):94-102. PubMed ID: 29233653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.
    Erwin AL
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27235477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer.
    Clayton GM; Klein DJ; Rickert KW; Patel SB; Kornienko M; Zugay-Murphy J; Reid JC; Tummala S; Sharma S; Singh SB; Miesel L; Lumb KJ; Soisson SM
    J Biol Chem; 2013 Nov; 288(47):34073-34080. PubMed ID: 24108127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway.
    Hyland SA; Eveland SS; Anderson MS
    J Bacteriol; 1997 Mar; 179(6):2029-37. PubMed ID: 9068651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A method to assay inhibitors of lipopolysaccharide synthesis.
    Hernick M; Fierke CA
    Methods Mol Med; 2008; 142():143-54. PubMed ID: 18437312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532.
    Ushiyama F; Takashima H; Matsuda Y; Ogata Y; Sasamoto N; Kurimoto-Tsuruta R; Ueki K; Tanaka-Yamamoto N; Endo M; Mima M; Fujita K; Takata I; Tsuji S; Yamashita H; Okumura H; Otake K; Sugiyama H
    Bioorg Med Chem; 2021 Jan; 30():115964. PubMed ID: 33385955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies.
    Kalinin DV; Agoglitta O; Van de Vyver H; Melesina J; Wagner S; Riemann B; Schäfers M; Sippl W; Löffler B; Holl R
    Bioorg Med Chem; 2019 May; 27(10):1997-2018. PubMed ID: 30954331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.
    Tomaras AP; McPherson CJ; Kuhn M; Carifa A; Mullins L; George D; Desbonnet C; Eidem TM; Montgomery JI; Brown MF; Reilly U; Miller AA; O'Donnell JP
    mBio; 2014 Sep; 5(5):e01551-14. PubMed ID: 25271285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Complex Structure of Protein AaLpxC from
    Fan S; Li D; Yan M; Feng X; Lv G; Wu G; Jin Y; Wang Y; Yang Z
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective mapping of chemical space for Pseudomonas aeruginosa deacetylase LpxC inhibitory potential.
    Kadam RU; Garg D; Roy N
    Chem Biol Drug Des; 2008 Jan; 71(1):45-56. PubMed ID: 18086152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives.
    Di Leo R; Cuffaro D; Rossello A; Nuti E
    Molecules; 2023 May; 28(11):. PubMed ID: 37298854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.